About
Stoic Venture Capital is a university-linked investor based in Sydney, founded in 2019, investing from pre-seed through Series B+. It describes itself as Australia's first university-focused venture fund, backing life sciences and biotech, hardware, robotics and sensors and climate and energy with cheques of roughly $100,000 to $1 million. Recent investments include Kinoxis Therapeutics and Ena Respiratory.
